Stress adaptation by NRF2 enables cancer cells to cope with challenging conditions in the tumor microenvironment, such as limited nutrient supply or oxidative stress from tumor-infiltrating immune cells, and is therefore responsible for resilience and therapy resistance in several cancer entities [29]. This evidence concerns the gene NFE2L2 and neoplasm.